Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis: Results from two randomized controlled trials

Mary L. Bouxsein, Peiqi Chen, Emmett V. Glass, David F. Kallmes, Pierre D. Delmas, Bruce H. Mitlak

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis: Results from two randomized controlled trials'. Together they form a unique fingerprint.

Medicine & Life Sciences